Full Text View
Tabular View
Study Results
Related Studies
Comparison of Sugammadex With Neostigmine as Reversal Agents for Rocuronium at Reappearance of T2 (Study P06101) (DANCHEONG)
This study has been completed.
Study NCT01050543   Information provided by Merck Sharp & Dohme Corp.

First Received on January 14, 2010.   Last Updated on August 1, 2014   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Interventions listed in this trial
More general drug interventions related to this trial
Sponsors listed in this trial